EUVIMEDEUVIMED entdecken
Crossref

Mouse uterine stem cells are affected by endocrine disruption and initiate uteropathies

Pushpa Singh iD, Deepa Bhartiya iD

Reproduction · 2023

DOI: 10.1530/rep-22-0337 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproduction, 2023. Verfasst von Pushpa Singh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Biology Department, ICMR-National Institute for Research in Reproductive & Child Health, Parel, Mumbai, India. Hauptthemen laut MEDLINE: Adenomyosis, Endometriosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 76 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In brief Incidence of uteropathies has increased in recent times, possibly due to exposure to endocrine-disrupting chemicals during early development. The present study shows that various uteropathies like endometrial cancer, adenomyosis, and endometriosis are interlinked and occur due to the dysfunction of tissue-resident, very small embryonic-like stem cells (VSELs). Abstract Underlying pathomechanisms leading to the initiation of uteropathies including non-receptive endometrium, hyperplasia, adenomyosis, endometriosis, fibroids, and cancer remain elusive. Two populations of stem cells exist in mouse uterus including pluripotent VSELs and ‘progenitors’ termed endometrial stem cells (EnSCs) which express ERα, ERβ, PR, and FSHR, participate in the regular remodelling, and maintain life-long homeostasis. The present study aimed to delineate possible stem cell origins for various uteropathies. For this, mouse pups were treated with oestradiol or diethylstilbestrol and were studied for adult onset of various uteropathies. Treatment resulted in disrupted oestrous cycles, reduced uterine weights, and marked hyperplasia in both epithelial and myometrial compartments, and the stromal compartment was also affected. VSELs were increased in numbers as judged by flow cytometry and increased expression of transcripts specific for Oct-4A, Sox-2, and Nanog, but their further differentiation into a receptive endometrium was affected. Reduced 5-methyl cytosine expression suggested global hypomethylation and was associated with several oncogenic events including loss of tumour-suppressor genes (Pten, p53), dysregulated DNA mismatch repair axis, and repair enzymes. Stem cells were epigenetically altered and showed increased expression of DNMTs, loss of imprinting loci (Igf2-H19, Dlk1-Meg3), and Ezh2. Increased co-expression of CD166 and ALDHA1 with OCT-4 in stem cells was associated with increased Esr-2 and reduced Pr in the endometrium, while both were several folds upregulated in the myometrium. Study results suggest that various uteropathies ensue due to the dysfunction of tissue-resident stem cells and provide huge scope for further research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenomyosisEndometriosisHumansFemaleMiceAnimalsHyperplasiaUterusEmbryonic Stem Cells

Autor:innen und Institutionen

  • Stem Cell Biology Department, ICMR-National Institute for Research in Reproductive & Child Health, Parel, Mumbai, India.

ORCID-Profile: Pushpa Singh, Deepa Bhartiya

Zitieren

APA

Singh, P., & Bhartiya, D. (2023). Mouse uterine stem cells are affected by endocrine disruption and initiate uteropathies. Reproduction. https://doi.org/10.1530/rep-22-0337

Vancouver

Singh P, Bhartiya D. Mouse uterine stem cells are affected by endocrine disruption and initiate uteropathies. Reproduction. 2023. doi:10.1530/rep-22-0337

BibTeX
@article{Singh2023,
  author = {Singh, Pushpa and Bhartiya, Deepa},
  title = {Mouse uterine stem cells are affected by endocrine disruption and initiate uteropathies},
  journal = {Reproduction},
  year = {2023},
  doi = {10.1530/rep-22-0337}
}
Kostenlos starten →